- 4009 Hackney Springs Ln, Sachse, TX 75048
Master Med-QUEST, Medicare, HMSA & 80+ Commercial Payer Requirements
Slash Claim Denials by 36% with CPT/HCPCS Code Precision
Navigate Hawaii's Five Med-QUEST Health Plans
Post Payments in 24-48 Hours—Zero Revenue Bottlenecks
Recover Outstanding A/R in 30 Days—42% Faster Than Industry Average
| Medicare Administrative Contractor (MAC) | Jurisdiction Code | MolDX Program Participant |
|---|---|---|
| Noridian Healthcare Solutions | Jurisdiction E (JE) | Yes (Z-Code Mandatory) |
Laboratory operations in Hawaii are governed by Noridian Healthcare Solutions Jurisdiction E. Facilities performing clinical, molecular, or specialized diagnostic testing must comply with Noridian’s MolDX registration procedures. Managing revenue cycles effectively demands accurate application of CPT and HCPCS modifiers, rigorous eligibility verification, and strict adherence to Noridian’s coverage thresholds for chronic disease monitoring.
First-pass clean claim rates of 98%
Denial rates below 3%
Days in A/R reduced from 78+ days to under 21 days
Overall revenue improvement of 8-12%
Denials reduced by 35%
AAPC/AHIMA certified coders ensure precise CPT, ICD-10, and HCPCS code assignment across all laboratory specialties. Accurate coding reduces denials, accelerates payments, and keeps your lab fully compliant with evolving payer requirements
Complete payer enrollment, CLIA certification management, and network participation setup across all insurance carriers. TransLabs manages every credentialing detail so that your laboratory gets paid in-network from day one without any administrative delays.
Real-time insurance verification, benefits investigation, and prior auth completed before specimen processing begins. Confirming coverage upfront eliminates preventable denials and protects your lab from unexpected reimbursement failures.
Patient registration, appointment coordination, insurance verification, and customer service excellence managed by experienced laboratory billing professionals. A well-run front office reduces downstream billing errors and creates a better experience.
Our labs billing services adhere strictly to CMS Laws and HIPAA guidelines
Coded to Noridian Healthcare Solutions's documentation standards, not a generic template.
We know where Med-QUEST's rules diverge from Medicare's.
We build Hawaii's state licensure rules into your workflow.
A single point of contact who knows your account.
Onboarding in 24 hours; no long-term contract.
TransLabs specializes exclusively in Hawaii laboratory facilities, giving us unmatched expertise in Med-QUEST health plan requirements, HMSA policies, TRICARE billing, Medicare Administrative Contractor (MAC) Jurisdiction E (JE) requirements, and Hawaii-specific payer regulations. Our 98% first-pass clean claim rate and 99% client retention rate reflect our commitment to excellence.
The top five denial reasons are:
Yes, all five Med-QUEST health plans (‘Ohana Health Plan, AlohaCare, HMSA, Kaiser Permanente, and UnitedHealthcare Community Plan) require prior authorization for molecular diagnostics, genetic testing, most tests over $500, and specialty immunology panels. Authorization requirements and processes vary by health plan. The authorization process typically takes 9-22 days depending on the health plan, complexity, and medical necessity documentation. TransLabs manages all five health plan portals to ensure approvals are secured before testing begins.
A Local Coverage Determination (LCD) is a Medicare policy that defines which tests are covered, which ICD-10 codes support medical necessity, and testing frequency limitations. Hawaii falls under Medicare Administrative Contractor (MAC) Jurisdiction E (JE), administered by Noridian Healthcare Solutions, which has strict LCDs for molecular and genetic testing. Billing a test with a non-covered diagnosis code results in automatic denial and potential audit exposure.
We pre-verify medical necessity before testing, submit prior authorizations with comprehensive documentation to the appropriate Med-QUEST health plan or commercial payer, use LCD-compliant diagnosis coding, attach required medical records, and proactively communicate with payers across time zones to prevent denials. For denied claims, we submit detailed appeals with peer-reviewed literature and clinical guidelines. Our molecular/genetic testing claim acceptance rate is 98%.
